Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Oral sustained-release products: pro's and con's.

Drug and therapeutics bulletin

[No authors listed]
PMID: 6468281
Drug Ther Bull. 1984 Jul 30;22(15):57-60.

No abstract available.

Cite
Oral sustained-release products: pro's and con's. Drug Ther Bull. 1984;22(15):57-60
(1984). Oral sustained-release products: pro's and con's. Drug and therapeutics bulletin, 22(15), 57-60.
"Oral sustained-release products: pro's and con's." Drug and therapeutics bulletin vol. 22,15 (1984): 57-60.
Oral sustained-release products: pro's and con's. Drug Ther Bull. 1984 Jul 30;22(15):57-60. PMID: 6468281.
Copy Download .nbib Format: NLM
Long-Acting Formulations: A Promising Approach for the Treatment of Chronic Diseases.

Current pharmaceutical design

Kumar SR, Mehta CH, Nayak UY.
PMID: 32634073
Curr Pharm Des. 2021;27(6):876-889. doi: 10.2174/1381612826666200707122012.

Medication and patient adherence are the two main aspects of any successful treatment of chronic disease. Even though diseases and its treatment existed for several hundred years, the treatment optimization for a given patient is still a researcher question...

Cite
Kumar SR, Mehta CH, Nayak UY. Long-Acting Formulations: A Promising Approach for the Treatment of Chronic Diseases. Curr Pharm Des. 2021;27(6):876-889doi: 10.2174/1381612826666200707122012.
Kumar, S. R., Mehta, C. H., & Nayak, U. Y. (2021). Long-Acting Formulations: A Promising Approach for the Treatment of Chronic Diseases. Current pharmaceutical design, 27(6), 876-889. https://doi.org/10.2174/1381612826666200707122012
Kumar, Somaraju R, et al. "Long-Acting Formulations: A Promising Approach for the Treatment of Chronic Diseases." Current pharmaceutical design vol. 27,6 (2021): 876-889. doi: https://doi.org/10.2174/1381612826666200707122012
Kumar SR, Mehta CH, Nayak UY. Long-Acting Formulations: A Promising Approach for the Treatment of Chronic Diseases. Curr Pharm Des. 2021;27(6):876-889. doi: 10.2174/1381612826666200707122012. PMID: 32634073.
Copy Download .nbib Format: NLM
Advancement in nanogel formulations provides controlled drug release.

International journal of pharmaceutics

Ahmed S, Alhareth K, Mignet N.
PMID: 32439585
Int J Pharm. 2020 Jun 30;584:119435. doi: 10.1016/j.ijpharm.2020.119435. Epub 2020 May 19.

Nanogels are currently considered as promising nanosized drug delivery carriers. Nanogels are made of a crosslinked polymeric network which could encapsulate both hydrophilic and hydrophobic drugs due to their tunable nature. The ability of nanogels to control drug release...

Cite
Ahmed S, Alhareth K, Mignet N. Advancement in nanogel formulations provides controlled drug release. Int J Pharm. 2020;584:119435doi: 10.1016/j.ijpharm.2020.119435.
Ahmed, S., Alhareth, K., & Mignet, N. (2020). Advancement in nanogel formulations provides controlled drug release. International journal of pharmaceutics, 584119435. https://doi.org/10.1016/j.ijpharm.2020.119435
Ahmed, Shayan, et al. "Advancement in nanogel formulations provides controlled drug release." International journal of pharmaceutics vol. 584 (2020): 119435. doi: https://doi.org/10.1016/j.ijpharm.2020.119435
Ahmed S, Alhareth K, Mignet N. Advancement in nanogel formulations provides controlled drug release. Int J Pharm. 2020 Jun 30;584:119435. doi: 10.1016/j.ijpharm.2020.119435. Epub 2020 May 19. PMID: 32439585.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries